search
Back to results

Efficacy of Aponeurectomy on the 2-year Recurrence Rate of Dupuytren's Disease (REMEDY)

Primary Purpose

Dupuytren's Disease

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Aponeurectomy with grafting
Aponeurectomy alone
Sponsored by
Elsan
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Dupuytren's Disease

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age ≥ 18 years
  • Carrier of Tubiana stage II-IV Dupuytren's disease on at least one or more rays, not previously operated
  • Indication of a surgery by aponeurectomy
  • Skin pinch of the posterior aspect of the arm of more than 1cm
  • Affiliation to a social security system
  • Patient informed of the study and having given informed consent

Exclusion Criteria:

  • Previous surgery of any kind for Dupuytren's disease
  • Involvement on the thumb only
  • Need for a total skin graft or a pedicle flap on all the rays to be treated
  • Active autoimmune disease
  • Previous treatment with collagenase
  • Pregnant and breastfeeding women
  • Patient under legal protection
  • Contraindications to MRI (criteria applicable only for patients from the coordinating center, not applicable for other centers)

Sites / Locations

  • Clinique du Diaconat
  • Institut Aquitain de la MainRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Aponeurectomy with grafting

Aponeurectomy alone

Arm Description

The experimental group evaluates the aponeurectomy associated with adipose tissue grafting.

The control group evaluates the aponeurectomy alone.

Outcomes

Primary Outcome Measures

2-year recurrence rate of Dupuytren's disease
Recurrence being defined as follows: appearance, at 2 years post-op compared to 6 weeks post-op, of a contracture of more than 20 degrees, with palpable cord, on any treated joint.

Secondary Outcome Measures

3-year recurrence rate in both groups
Recurrence being defined as follows: Appearance of a contracture of more than 20 degrees, with palpable cord, on any treated joint, at 3 years post-op compared to 6 weeks post-op
5-year recurrence rate in both groups
Recurrence being defined as follows: Appearance of a contracture of more than 20 degrees, with palpable cord, on any treated joint, at 5 years post-op compared to 6 weeks post-op
Comparison of the appearance of scars in both groups
Use of questionnaire The Patient and Observer Scar Assessment Scale (POSAS). This questionnaire consists of 2 separate scales of 6 items each (one scale for the observer and one scale for the patient). Each item is evaluated on 10 points. The lowest score is "1" which corresponds to the appearance of normal skin. A score of 10 indicates the greatest deviation from normal skin. The total score for each of the scales is obtained by adding the score for each of the 6 items. This total score can vary between 6 and 60 for each of the scales.
Comparison of the appearance of scars in both groups
Use of questionnaire The Patient and Observer Scar Assessment Scale (POSAS). This questionnaire consists of 2 separate scales of 6 items each (one scale for the observer and one scale for the patient). Each item is evaluated on 10 points. The lowest score is "1" which corresponds to the appearance of normal skin. A score of 10 indicates the greatest deviation from normal skin. The total score for each of the scales is obtained by adding the score for each of the 6 items. This total score can vary between 6 and 60 for each of the scales.
Comparison of the complication rates in both groups
Complications are defined as Hematoma, infection, graft lysis, disunion or nerve damage.
Comparison of the complication rates in both groups
Complications are defined as Hematoma, infection, graft lysis, disunion or nerve damage.
Comparison of the rate of occurrence of algodystrophy, regardless of cause
Collection of information on the occurrence of algodystrophy, considered as Adverse Event of Special Interest.
Comparison of the rate of occurrence of algodystrophy, regardless of cause
Collection of information on the occurrence of algodystrophy, considered as Adverse Event of Special Interest.
Comparison of the rate of occurrence of algodystrophy, regardless of cause
Collection of information on the occurrence of algodystrophy, considered as Adverse Event of Special Interest.
Comparison of the rate of occurrence of algodystrophy, regardless of cause
Collection of information on the occurrence of algodystrophy, considered as Adverse Event of Special Interest.
Evaluation of hypodermic fat volume loss
Measurement of hypodermal fat thickness on MRI for five patients of experimental group, only include in the coordinating center. The evolution is measured with preoperative, immediate postoperative (day of surgery) and 1-year MRI.
Comparison of the effect on quality of life in both groups
Use of Quick Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire. The score consists of 11 questions that assess the function of the upper limb for the gestures of daily life. The final score is between 0 and 100, with 0 corresponding to normal function, and 100 to almost no function.
Comparison of the effect on quality of life in both groups
Use of Quick Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire. The score consists of 11 questions that assess the function of the upper limb for the gestures of daily life. The final score is between 0 and 100, with 0 corresponding to normal function, and 100 to almost no function.
Comparison of the effect on quality of life in both groups
Use of Quick Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire. The score consists of 11 questions that assess the function of the upper limb for the gestures of daily life. The final score is between 0 and 100, with 0 corresponding to normal function, and 100 to almost no function.
Comparison of the effect on quality of life in both groups
Use of Quick Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire. The score consists of 11 questions that assess the function of the upper limb for the gestures of daily life. The final score is between 0 and 100, with 0 corresponding to normal function, and 100 to almost no function.
Evaluation of the safety of aponectomy surgery associated or not with adipose tissue grafting
Collection of adverse events
Evaluation of the primary endpoint on the second hand operated on.
The surgery being done with or without fat according to the treatment of the 1st randomized hand (cross-over scheme). Data collection for the second surgery only if it occurs between the 1st hand surgery and the patient's protocol discharge.

Full Information

First Posted
September 24, 2021
Last Updated
August 23, 2023
Sponsor
Elsan
search

1. Study Identification

Unique Protocol Identification Number
NCT05067764
Brief Title
Efficacy of Aponeurectomy on the 2-year Recurrence Rate of Dupuytren's Disease
Acronym
REMEDY
Official Title
Multicenter, Randomized, Open-label Study Evaluating the Efficacy of Aponeurectomy Associated With Adipose Tissue Grafting Compared to Aponeurectomy Alone, on the 2-year Recurrence Rate of Dupuytren's Disease (REMEDY).
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 13, 2022 (Actual)
Primary Completion Date
June 1, 2024 (Anticipated)
Study Completion Date
June 1, 2029 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Elsan

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Dupuytren's disease is a frequent hereditary disease in Northern Europe. It is a degenerative disease affecting the palmar aponeurosis of the hand. It develops a progressive contractile fibrosis which cuts the hypodermic fatty tissue, adheres to the skin and the phalanges, gradually bending the affected rays, resulting in significant functional impotence. Various medical and surgical treatments are available.
Detailed Description
Among these treatments, none to date can eliminate recurrences, which are still too frequent. Open aponeurectomy (consisting of surgical curettage of the fibrotic cords) remains for the moment the reference technique for treating Dupuytren's disease, with recurrences (between 12 and 39%), but less frequent than the needle technique (50 to 85%). Could the addition of adipose tissue in the resection areas of Dupytren's fibrosis reduce the rate of recurrence (by the inhibitory action of ADCs on myofibroblasts) in addition to reconstructing the hypodermis in the cavity left by the resection of the cords and improving the quality of the scars? The investigators insist on the fact that this is a homotopic and homologous adipose tissue graft, in closed circuit without denaturation or adjuvant products. Since, to our knowledge, no other team has used "lipofilling" as an adjuvant treatment to the open resection technique of Dupuytren's cords (aponeurectomy), the investigators first conducted a clinical feasibility and safety study on 70 patients between 2012 and 2017 (currently being published by Springer Editions). The investigators now wish to conduct a prospective comparative study between patients operated by aponeurectomy WITH (experimental group) and WITHOUT (control group) addition of autologous adipose tissue in the resection areas of Dupuytren's cords.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dupuytren's Disease

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Interventional, prospective, therapeutic, comparative, randomized controlled open-label, superiority, multicenter, national study.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
150 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Aponeurectomy with grafting
Arm Type
Experimental
Arm Description
The experimental group evaluates the aponeurectomy associated with adipose tissue grafting.
Arm Title
Aponeurectomy alone
Arm Type
Active Comparator
Arm Description
The control group evaluates the aponeurectomy alone.
Intervention Type
Procedure
Intervention Name(s)
Aponeurectomy with grafting
Intervention Description
The lipofilling is performed, once the incisions are closed and is performed with the Puregraft® system. The fat graft is taken from the posterior, medial and anterior sides of the arm, by skin puncture. Approximately 10 cc are harvested, allowing a reinjection of about 2 cc per digital radius treated. After conditioning, the fat graft is redistributed to the curettage areas through the skin incisions.
Intervention Type
Procedure
Intervention Name(s)
Aponeurectomy alone
Intervention Description
The patient is installed in dorsal decubitus position and the arm to be treated is anesthetized by axillary block. The procedure is performed in the operating room, respecting all the rules of asepsis and safety in force. A tourniquet is placed on the arm to be treated and inflated to 250mmHg. Broken incisions are then made opposite the cords to be excised, which are located by palpation. Once the noble elements have been identified, the excision of the cords and fibrous nodules can be done as completely as possible. Sometimes an arthrolysis procedure is necessary in order to restore extension to a joint that has been fixed in a flexion position for several years. Skin closure is most often possible by direct suture or by means of local fatty skin flaps. In some cases, the surgeon may use total skin grafts, or directed healing in certain areas where direct skin suture is not possible.
Primary Outcome Measure Information:
Title
2-year recurrence rate of Dupuytren's disease
Description
Recurrence being defined as follows: appearance, at 2 years post-op compared to 6 weeks post-op, of a contracture of more than 20 degrees, with palpable cord, on any treated joint.
Time Frame
2 Years after intervention
Secondary Outcome Measure Information:
Title
3-year recurrence rate in both groups
Description
Recurrence being defined as follows: Appearance of a contracture of more than 20 degrees, with palpable cord, on any treated joint, at 3 years post-op compared to 6 weeks post-op
Time Frame
3 Years after intervention
Title
5-year recurrence rate in both groups
Description
Recurrence being defined as follows: Appearance of a contracture of more than 20 degrees, with palpable cord, on any treated joint, at 5 years post-op compared to 6 weeks post-op
Time Frame
5 Years after intervention
Title
Comparison of the appearance of scars in both groups
Description
Use of questionnaire The Patient and Observer Scar Assessment Scale (POSAS). This questionnaire consists of 2 separate scales of 6 items each (one scale for the observer and one scale for the patient). Each item is evaluated on 10 points. The lowest score is "1" which corresponds to the appearance of normal skin. A score of 10 indicates the greatest deviation from normal skin. The total score for each of the scales is obtained by adding the score for each of the 6 items. This total score can vary between 6 and 60 for each of the scales.
Time Frame
1 Year after intervention
Title
Comparison of the appearance of scars in both groups
Description
Use of questionnaire The Patient and Observer Scar Assessment Scale (POSAS). This questionnaire consists of 2 separate scales of 6 items each (one scale for the observer and one scale for the patient). Each item is evaluated on 10 points. The lowest score is "1" which corresponds to the appearance of normal skin. A score of 10 indicates the greatest deviation from normal skin. The total score for each of the scales is obtained by adding the score for each of the 6 items. This total score can vary between 6 and 60 for each of the scales.
Time Frame
2 Years after intervention
Title
Comparison of the complication rates in both groups
Description
Complications are defined as Hematoma, infection, graft lysis, disunion or nerve damage.
Time Frame
1 Week after intervention
Title
Comparison of the complication rates in both groups
Description
Complications are defined as Hematoma, infection, graft lysis, disunion or nerve damage.
Time Frame
6 Weeks after intervention
Title
Comparison of the rate of occurrence of algodystrophy, regardless of cause
Description
Collection of information on the occurrence of algodystrophy, considered as Adverse Event of Special Interest.
Time Frame
1 Year after intervention
Title
Comparison of the rate of occurrence of algodystrophy, regardless of cause
Description
Collection of information on the occurrence of algodystrophy, considered as Adverse Event of Special Interest.
Time Frame
2 Years after intervention
Title
Comparison of the rate of occurrence of algodystrophy, regardless of cause
Description
Collection of information on the occurrence of algodystrophy, considered as Adverse Event of Special Interest.
Time Frame
3 Years after intervention
Title
Comparison of the rate of occurrence of algodystrophy, regardless of cause
Description
Collection of information on the occurrence of algodystrophy, considered as Adverse Event of Special Interest.
Time Frame
5 Years after intervention
Title
Evaluation of hypodermic fat volume loss
Description
Measurement of hypodermal fat thickness on MRI for five patients of experimental group, only include in the coordinating center. The evolution is measured with preoperative, immediate postoperative (day of surgery) and 1-year MRI.
Time Frame
1 Year after intervention
Title
Comparison of the effect on quality of life in both groups
Description
Use of Quick Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire. The score consists of 11 questions that assess the function of the upper limb for the gestures of daily life. The final score is between 0 and 100, with 0 corresponding to normal function, and 100 to almost no function.
Time Frame
6 Weeks after intervention
Title
Comparison of the effect on quality of life in both groups
Description
Use of Quick Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire. The score consists of 11 questions that assess the function of the upper limb for the gestures of daily life. The final score is between 0 and 100, with 0 corresponding to normal function, and 100 to almost no function.
Time Frame
1 Year after intervention
Title
Comparison of the effect on quality of life in both groups
Description
Use of Quick Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire. The score consists of 11 questions that assess the function of the upper limb for the gestures of daily life. The final score is between 0 and 100, with 0 corresponding to normal function, and 100 to almost no function.
Time Frame
2 Years after intervention
Title
Comparison of the effect on quality of life in both groups
Description
Use of Quick Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire. The score consists of 11 questions that assess the function of the upper limb for the gestures of daily life. The final score is between 0 and 100, with 0 corresponding to normal function, and 100 to almost no function.
Time Frame
5 Years after intervention
Title
Evaluation of the safety of aponectomy surgery associated or not with adipose tissue grafting
Description
Collection of adverse events
Time Frame
6 Weeks after intervention
Title
Evaluation of the primary endpoint on the second hand operated on.
Description
The surgery being done with or without fat according to the treatment of the 1st randomized hand (cross-over scheme). Data collection for the second surgery only if it occurs between the 1st hand surgery and the patient's protocol discharge.
Time Frame
Within five years after intervention

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age ≥ 18 years Carrier of Tubiana stage II-IV Dupuytren's disease on at least one or more rays, not previously operated Indication of a surgery by aponeurectomy Skin pinch of the posterior aspect of the arm of more than 1cm Affiliation to a social security system Patient informed of the study and having given informed consent Exclusion Criteria: Previous surgery of any kind for Dupuytren's disease Involvement on the thumb only Need for a total skin graft or a pedicle flap on all the rays to be treated Active autoimmune disease Previous treatment with collagenase Pregnant and breastfeeding women Patient under legal protection Contraindications to MRI (criteria applicable only for patients from the coordinating center, not applicable for other centers)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Elias SAWAYA, MD
Phone
(0)663420278
Ext
+33
Email
esawaya.md@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elias SAWAYA, MD
Organizational Affiliation
Institut Aquitain de la Main
Official's Role
Principal Investigator
Facility Information:
Facility Name
Clinique du Diaconat
City
Mulhouse
ZIP/Postal Code
68100
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Chihab TALEB, MD
Phone
03 89 70 34 70
Facility Name
Institut Aquitain de la Main
City
Pessac
ZIP/Postal Code
33600
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Elias Sawaya, MD
Phone
(0)663420278
Ext
+33
Email
esawaya.md@gmail.com
First Name & Middle Initial & Last Name & Degree
Charlène PY, CRA
Email
charlene.py@elsan.care
First Name & Middle Initial & Last Name & Degree
Elias Sawaya, MD

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
30489526
Citation
Selles RW, Zhou C, Kan HJ, Wouters RM, van Nieuwenhoven CA, Hovius SER. Percutaneous Aponeurotomy and Lipofilling versus Limited Fasciectomy for Dupuytren's Contracture: 5-Year Results from a Randomized Clinical Trial. Plast Reconstr Surg. 2018 Dec;142(6):1523-1531. doi: 10.1097/PRS.0000000000004982.
Results Reference
background
PubMed Identifier
24570630
Citation
Henry M. Dupuytren's disease: current state of the art. Hand (N Y). 2014 Mar;9(1):1-8. doi: 10.1007/s11552-013-9563-0.
Results Reference
background
PubMed Identifier
24969497
Citation
Engstrand C, Krevers B, Nylander G, Kvist J. Hand function and quality of life before and after fasciectomy for Dupuytren contracture. J Hand Surg Am. 2014 Jul;39(7):1333-1343.e2. doi: 10.1016/j.jhsa.2014.04.029.
Results Reference
background
PubMed Identifier
16936550
Citation
Coleman SR. Structural fat grafting: more than a permanent filler. Plast Reconstr Surg. 2006 Sep;118(3 Suppl):108S-120S. doi: 10.1097/01.prs.0000234610.81672.e7.
Results Reference
background
PubMed Identifier
11304456
Citation
Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001 Apr;7(2):211-28. doi: 10.1089/107632701300062859.
Results Reference
background
PubMed Identifier
19730294
Citation
Mojallal A, Lequeux C, Shipkov C, Breton P, Foyatier JL, Braye F, Damour O. Improvement of skin quality after fat grafting: clinical observation and an animal study. Plast Reconstr Surg. 2009 Sep;124(3):765-774. doi: 10.1097/PRS.0b013e3181b17b8f.
Results Reference
background
PubMed Identifier
23924646
Citation
Verhoekx JSN, Mudera V, Walbeehm ET, Hovius SER. Adipose-derived stem cells inhibit the contractile myofibroblast in Dupuytren's disease. Plast Reconstr Surg. 2013 Nov;132(5):1139-1148. doi: 10.1097/PRS.0b013e3182a3bf2b.
Results Reference
background
PubMed Identifier
12954251
Citation
Foucher G, Medina J, Navarro R. Percutaneous needle aponeurotomy: complications and results. J Hand Surg Br. 2003 Oct;28(5):427-31. doi: 10.1016/s0266-7681(03)00013-5.
Results Reference
background
PubMed Identifier
28505187
Citation
Kan HJ, Verrijp FW, Hovius SER, van Nieuwenhoven CA; Dupuytren Delphi Group; Selles RW. Recurrence of Dupuytren's contracture: A consensus-based definition. PLoS One. 2017 May 15;12(5):e0164849. doi: 10.1371/journal.pone.0164849. eCollection 2017. Erratum In: PLoS One. 2019 Apr 25;14(4):e0216313.
Results Reference
background
PubMed Identifier
15866967
Citation
Beaton DE, Wright JG, Katz JN; Upper Extremity Collaborative Group. Development of the QuickDASH: comparison of three item-reduction approaches. J Bone Joint Surg Am. 2005 May;87(5):1038-46. doi: 10.2106/JBJS.D.02060.
Results Reference
background
PubMed Identifier
19297202
Citation
Mintken PE, Glynn P, Cleland JA. Psychometric properties of the shortened disabilities of the Arm, Shoulder, and Hand Questionnaire (QuickDASH) and Numeric Pain Rating Scale in patients with shoulder pain. J Shoulder Elbow Surg. 2009 Nov-Dec;18(6):920-6. doi: 10.1016/j.jse.2008.12.015. Epub 2009 Mar 17.
Results Reference
background

Learn more about this trial

Efficacy of Aponeurectomy on the 2-year Recurrence Rate of Dupuytren's Disease

We'll reach out to this number within 24 hrs